July 2, 2025 /

Webinar: Edgewise Therapeutics – Update on Sevasemten Program in Becker and Duchenne Muscular Dystrophies

Parent Project Muscular Dystrophy by: Parent Project Muscular Dystrophy

Edgewise Therapeutics recently joined PPMD for a community webinar for an update on the company’s sevasemten program in Duchenne and Becker. The Edgewise team reviewed new Open-label Extension MESA data in Becker, as well as interim data from the ongoing LYNX and FOX Phase 2 studies.

Research & Clinical Trial Webinars,
Webinars

Join Our Mailing List